Cardiac fibroma

Last updated
Cardiac fibroma
Other namesCardiac fibrous hamartoma, Fibroelastic hamartoma of heart
Specialty Cardiology/oncology

Cardiac fibroma, also known as cardiac fibromatosis, cardiac fibrous hamartoma, fibroelastic hamartoma of heart and fibroma of heart is the second highest type of primary cardiac tumor seen in infants and children. [1] This benign tumor made by connective tissue and fibroblast is largely observed in the ventricles of the heart. [2] The left ventricle is the most common location of cardiac fibroma and accounts for approximately 57% of cardiac fibroma cases followed by the right ventricle with 27.5% of cases. [1] Symptoms of the disease depend on the size of the tumor, its location relative to the conduction system, and whether it obstructs blood flow. Two-thirds of children with this tumor are asymptomatic, showing no signs and symptoms. Therefore the cause of cardiac fibroma is unexplained but has been associated with Gorlin Syndrome. [3] Echocardiography is the primarily diagnostic method used to detect if an individual has cardiac fibroma. [4] Resection of the tumor is recommended however heart transplantation is done if surgery is not possible. Overall prognosis of resection is favorable and the chance of recurrence is scarcely reported. [5] [6] [7]

Contents

Signs and symptoms

Signs and symptoms in cardiac fibroma are nonspecific, some individuals experience arrhythmias, dyspnea, cyanosis, chest-pain and sudden mortality. [1] In addition, the majority of individuals with cardiac fibroma are asymptomatic therefore leading to signs and symptoms that depend on the size and location of the tumor. [4] Tumors range from millimeters to extensive tumors in the range of 12.5 x 10.0 x 8.5 cm. [8] For instance, individuals with larger tumors due to cardiac fibroma which include the conduction system of the heart can demonstrate cardiac dysrhythmias as a symptom. [9]

Cause

The cause of cardiac fibroma is still unknown. However, some tumors have been found to be associated with Gorlin syndrome which is also known as Nevoid Basal Cell Carcinoma Syndrome (NBCCS). NBCCS is a genetic condition that affects various parts of the body and increases the possibility of acquiring distinct cancerous and non cancerous tumors. [3]

Mechanism

The mechanism behind cardiac fibromas is still unclear. Fibromas have a homogeneous mass of fibroblasts mixed with an abundance of collagen and elastic fibers. These masses represent mesenchymal growth, but lack other mesenchymal elements, such as blood vessels, cartilage bone, and muscle. [8] [10] These masses often entrap cardiomyocytes, which are muscle cells that make up the cardiac muscle; cells decrease while collagen content increase in these masses. [10] The growth of cardiac fibromas are also slow and produce detrimental physical effects. This is due to infiltration and replacement of myocardium which protrude into the cavity of the heart. These tumors usually occur within the anterior wall of the left ventricle or the interventricular septum and rarely involves the right ventricle. [11] Large fibromas bulge into the cavity of the chamber, interfering with the functions of heart valves and blood flow through the heart. When the left ventricular is obstructed, the outflow tract may give rise to a failed diagnosis of congenital subaortic stenosis. Moreover, it can cause severe congestive heart failure. Cardiac fibromas may present lymphocyte and monocyte aggregates, as well as areas of calcification, which are shown on a chest x-ray or CT scan. The dimensions of these masses and the location cause clinical symptoms.[ citation needed ]

Diagnosis

Early and precise diagnosis of cardiac fibroma can lead to healing and avoidance of surgery. Echocardiography is the preferred initial method of diagnosis for cardiac fibroma. This is due to the exams non-invasiveness, reduced cost and extensive availability. Echocardiography depicts the morphologic appearance, region and motion of the tumor. [4] On the other hand, additional examinations such as Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are also conducted for additional diagnostic information. The CT exam provides precise spatial resolution of the tumor meanwhile an MRI provides a comprehensive overview of tissue characterization and does not expose the patient to radiation. [4] Tumor biopsy is utilized in cardiac fibroma as the gold standard to confirmation a patient diagnosis with cardiac fibroma. Family medical history and physical examination of an individual is also used as a diagnostic method, close examination of the heart is concluded along with careful detection of any abnormal heart sounds. [12]

Treatment

Cardiac fibroma is commonly treated through surgical excision procedures. The removal of the cardiac tumor requires open heart surgery. During surgery, the tumor and tissues around it is removed to reduce the risk of the tumor returning. [13] Recovery after surgery is between 4–5 days in the hospital and 6 weeks in total. An echocardiogram is taken every year after the surgery to make sure the tumor has not returned or formed any new growth. [13] On the other hand, if surgery is not possible, a heart transplantation is required. [1]

Prognosis

Cardiac fibromas in infancy which are unable to be removed surgically due to size and extensive myocardial infiltration, have a poor prognosis. The is due to the high ratio of tumor-to-heart size that may produce low cardiac output and as a result lead to a poorer prognosis. [6] As a result, defibrillator implantation or cardiac transplantation may be required. [1] However, tumors that are able to be surgically removed even incompletely have a good prognosis. Long-term survival after surgical resection is favorable, and the chance of recurrence is scarcely reported. [5] [6] [7]

Epidemiology

Cardiac fibromas account for 12%-16% of primary cardiac tumors in children. Therefore, leading it to be the second most common benign cardiac tumor in children. However, it has rarely been found in adults but mainly found in infants under the age of one. [1]

Research directions

Literature Survey on Epidemiology and Pathology of Cardiac Fibroma:

During this study, researchers searched through the literature databases on cardiac fibroma to find factors that predict poor outcomes that lead to death. Researchers found that patients who did not survive were significantly younger than those who did survive. These results suggest that younger individuals diagnosed with cardiac fibroma are associated with a poorer outcome. [6] Researchers found no significant difference between the maximum diameter of the tumor between age groups. However, although younger individuals have smaller hearts, the high ratio of tumor-to-heart sizes may generate low cardiac output, which leads to a poor outcome. In addition, literature revealed that 18 of 178 patients with cardiac fibroma were diagnosed during prenatal and neonatal periods, resulting in the tumor having a certain size regardless of the child's age. These findings suggest that cardiac fibromas may be a congenital disorder. [6]

Successful Surgical Excision of a Large Cardiac Fibroma in an Asymptomatic Child:

A 3-year-old girl, who was asymptomatic, underwent a successful surgical excision of a large cardiac fibroma. The individual had frequent coughs, and therefore underwent several diagnostic exams to diagnose the cause of her frequent cough. A cardiac mass was found on the echocardiograph and later was confirmed by magnetic resonance imaging (MRI). [14] The cardiac mass was monitored and after 24 hours, it showed sinus rhythms of normal variability. In addition, the mass dimensions were 38 X 28 mm in the apical area of the left ventricle. A surgical procedure was recommended due to the risk of ventricular arrhythmias and sudden cardiac death. The surgery was a success and physicians were able to remove the entire tumor without any complications. Follow-up evaluations at six-months and a year showed the patient in good health and no signs of tumor recurrence. [14]

Primary Cardiac Tumors in Children: A Center's Experience:

The Department of Cardiac Surgery Children's Hospital in China conducted a study to analyze different characteristics and outcomes of pediatric patients who have primary cardiac tumors treated in their center. [15] They had sixteen patients with primary cardiac tumors between the ages of 1–13 years. All patients were diagnosed by echocardiography, MRI, and CT. 15 of the 16 patients were able to get successful remove of their mass and one patient had partial resection. However, one patient did die during surgery due to low cardiac output syndrome after five days of their initial surgery to remove their mass. [15] The pathological examination of the cardiac masses showed that rhabdomyoma is the most frequent tumor in children, followed by myxoma and fibromas; morbidity of rhabdomyomas and fibromas were reported higher in infancy, while myxomas were more frequent in older children. [15]

Related Research Articles

<span class="mw-page-title-main">Tetralogy of Fallot</span> Type of congenital heart defect

Tetralogy of Fallot (TOF), formerly known as Steno-Fallot tetralogy, is a congenital heart defect characterized by four specific cardiac defects. Classically, the four defects are:

<span class="mw-page-title-main">Tuberous sclerosis</span> Genetic condition causing non-cancerous tumours

Tuberous sclerosis complex (TSC) is a rare multisystem autosomal dominant genetic disease that causes non-cancerous tumours to grow in the brain and on other vital organs such as the kidneys, heart, liver, eyes, lungs and skin. A combination of symptoms may include seizures, intellectual disability, developmental delay, behavioral problems, skin abnormalities, lung disease, and kidney disease.

Hypertrophic cardiomyopathy is a condition in which muscle tissues of the heart become thickened without an obvious cause. The parts of the heart most commonly affected are the interventricular septum and the ventricles. This results in the heart being less able to pump blood effectively and also may cause electrical conduction problems.

<span class="mw-page-title-main">Aortic regurgitation</span> Medical condition

Aortic regurgitation (AR), also known as aortic insufficiency (AI), is the leaking of the aortic valve of the heart that causes blood to flow in the reverse direction during ventricular diastole, from the aorta into the left ventricle. As a consequence, the cardiac muscle is forced to work harder than normal.

<span class="mw-page-title-main">Aneurysm of sinus of Valsalva</span> Medical condition

Aneurysm of the aortic sinus, also known as the sinus of Valsalva, is a rare abnormality of the aorta, the largest artery in the body. The aorta normally has three small pouches that sit directly above the aortic valve, and an aneurysm of one of these sinuses is a thin-walled swelling. Aneurysms may affect the right (65–85%), non-coronary (10–30%), or rarely the left coronary sinus. These aneurysms may not cause any symptoms but if large can cause shortness of breath, palpitations or blackouts. Aortic sinus aneurysms can burst or rupture into adjacent cardiac chambers, which can lead to heart failure if untreated.

<span class="mw-page-title-main">Mitral regurgitation</span> Form of valvular heart disease

Mitral regurgitation(MR), also known as mitral insufficiency or mitral incompetence, is a form of valvular heart disease in which the mitral valve is insufficient and does not close properly when the heart pumps out blood. It is the abnormal leaking of blood backwards – regurgitation from the left ventricle, through the mitral valve, into the left atrium, when the left ventricle contracts. Mitral regurgitation is the most common form of valvular heart disease.

<span class="mw-page-title-main">Rhabdomyoma</span> Medical condition

A rhabdomyoma is a benign tumor of striated muscle. Rhabdomyomas may be either cardiac or extracardiac. Extracardiac forms of rhabdomyoma are sub-classified into three distinct types: adult type, fetal type, and genital type.

<span class="mw-page-title-main">Angiosarcoma</span> Cancer of the lining of the blood or lymphatic vessels

Angiosarcoma is a rare and aggressive cancer that starts in the endothelial cells that line the walls of blood vessels or lymphatic vessels. Since they are made from vascular lining, they can appear anywhere and at any age, but older people are more commonly affected, and the skin is the most affected area, with approximately 60% of cases being cutaneous. Specifically, the scalp makes up ~50% of angiosarcoma cases, but this is still <0.1% of all head and neck tumors. Since angiosarcoma is an umbrella term for many types of tumor that vary greatly in origin and location, many symptoms may occur, from completely asymptomatic to non-specific symptoms like skin lesions, ulceration, shortness of breath and abdominal pain. Multiple-organ involvement at time of diagnosis is common and makes it difficult to ascertain origin and how to treat it.

<span class="mw-page-title-main">Hamartoma</span> Tumour-like overgrowth due to a systemic genetic condition

A hamartoma is a mostly benign, local malformation of cells that resembles a neoplasm of local tissue but is usually due to an overgrowth of multiple aberrant cells, with a basis in a systemic genetic condition, rather than a growth descended from a single mutated cell (monoclonality), as would typically define a benign neoplasm/tumor. Despite this, many hamartomas are found to have clonal chromosomal aberrations that are acquired through somatic mutations, and on this basis the term hamartoma is sometimes considered synonymous with neoplasm. Hamartomas are by definition benign, slow-growing or self-limiting, though the underlying condition may still predispose the individual towards malignancies.

<span class="mw-page-title-main">Atrioventricular septal defect</span> Medical condition

Atrioventricular septal defect (AVSD) or atrioventricular canal defect (AVCD), also known as "common atrioventricular canal" or "endocardial cushion defect" (ECD), is characterized by a deficiency of the atrioventricular septum of the heart that creates connections between all four of its chambers. It is a very specific combination of 3 defects:

<span class="mw-page-title-main">Pericardial effusion</span> Medical condition

A pericardial effusion is an abnormal accumulation of fluid in the pericardial cavity. The pericardium is a two-part membrane surrounding the heart: the outer fibrous connective membrane and an inner two-layered serous membrane. The two layers of the serous membrane enclose the pericardial cavity between them. This pericardial space contains a small amount of pericardial fluid, normally 15-50 mL in volume. The pericardium, specifically the pericardial fluid provides lubrication, maintains the anatomic position of the heart in the chest, and also serves as a barrier to protect the heart from infection and inflammation in adjacent tissues and organs.

<span class="mw-page-title-main">Mediastinal tumors</span> Medical condition

A mediastinal tumor is a tumor in the mediastinum, the cavity that separates the lungs from the rest of the chest. It contains the heart, esophagus, trachea, thymus, and aorta. The most common mediastinal masses are neurogenic tumors, usually found in the posterior mediastinum, followed by thymoma (15–20%) located in the anterior mediastinum. Lung cancer typically spreads to the lymph nodes in the mediastinum.

<span class="mw-page-title-main">Primary tumors of the heart</span> Medical condition

Primary tumors of the heart are extremely rare tumors that arise from the normal tissues that make up the heart. The incidence of primary cardiac tumors has been found to be approximately 0.02%. This is in contrast to secondary tumors of the heart, which are typically either metastatic from another part of the body, or infiltrate the heart via direct extension from the surrounding tissues. Metastatic tumors to the heart are about 20 times more common than primary cardiac tumors.

<span class="mw-page-title-main">Colloid cyst</span> Medical condition

A colloid cyst is a non-malignant tumor in the brain. It consists of a gelatinous material contained within a membrane of epithelial tissue. It is almost always found just posterior to the foramen of Monro in the anterior aspect of the third ventricle, originating from the roof of the ventricle. Because of its location, it can cause obstructive hydrocephalus and increased intracranial pressure. Colloid cysts represent 0.5–1.0% of intracranial tumors.

<span class="mw-page-title-main">Thymic carcinoma</span> Medical condition

Thymic carcinoma, or type C thymoma, is a malignancy of the thymus. It is a rare cancer that is often diagnosed at advanced stages. Recurrence following treatment is common, and thymic carcinoma is associated with a poor prognosis.

<span class="mw-page-title-main">Papillary fibroelastoma</span> Medical condition

A papillary fibroelastoma is a primary tumor of the heart that typically involves one of the valves of the heart. Papillary fibroelastomas, while considered uncommon, make up about 10 percent of all primary tumors of the heart. They are the third most common type of primary tumor of the heart, behind cardiac myxomas and cardiac lipomas.

<span class="mw-page-title-main">Anomalous left coronary artery from the pulmonary artery</span> Medical condition

Anomalous left coronary artery from the pulmonary artery is a rare congenital anomaly occurring in approximately 1 in 300,000 liveborn children. The diagnosis comprises between 0.24 and 0.46% of all cases of congenital heart disease. The anomalous left coronary artery (LCA) usually arises from the pulmonary artery instead of the aortic sinus. In fetal life, the high pressure in the pulmonic artery and the fetal shunts enable oxygen-rich blood to flow in the LCA. By the time of birth, the pressure will decrease in the pulmonic artery and the child will have a postnatal circulation. The myocardium which is supplied by the LCA, will therefore be dependent on collateral blood flow from the other coronary arteries, mainly the RCA. Because the pressure in RCA exceeds the pressure in LCA a collateral circulation will increase. This situation ultimately can lead to blood flowing from the RCA into the LCA retrograde and into the pulmonary artery, thus forming a left-to-right shunt.

Ectopic thymus is a condition where thymus tissue is found in an abnormal location. It usually does not cause symptoms, but may leads to a mass in the neck that may compress the trachea and the esophagus. It is thought to be the result of either a failure of descent or a failure of involution of normal thymus tissue. It may be diagnosed with radiology, such as an ultrasound or magnetic resonance imaging. If it causes illness, surgery can be used to remove it. Recurrence after surgery is very unlikely.

<span class="mw-page-title-main">Ovarian fibroma</span> Medical condition

The ovarian fibroma, also fibroma, is a benign sex cord-stromal tumour.

<span class="mw-page-title-main">Angiocentric glioma</span>

Angiocentric glioma (AG) refers to a rare neuroepithelial tumor when the superficial brain malignant cells enclose the brain vessels, commonly found in children and young adults. Initially identified in 2005 by Wang and his team from the University of Texas, AG was classified as Grade I by 2007 WHO Classification of Tumors of the Central Nervous System due to its benign clinical behavior, low proliferation index, and curative properties. AG primarily affects children and young adults at an average initial diagnosis age of 16 years old. Over 85% AG patients experience intractable seizures since childhood, especially partial epilepsy.

References

  1. 1 2 3 4 5 6 Zheng, Xing-Ju; Song, Bin (October 2018). "Left ventricle primary cardiac fibroma in an adult: A case report". Oncology Letters. 16 (4): 5463–5465. doi:10.3892/ol.2018.9260. ISSN   1792-1074. PMC   6144884 . PMID   30250618.
  2. ↑ Rajput, Furqan A.; Limaiem, Faten (2019), "Cardiac Fibroma", StatPearls, StatPearls Publishing, PMID   30725766 , retrieved 2019-11-05
  3. 1 2 Reference, Genetics Home. "Gorlin syndrome". Genetics Home Reference. Retrieved 2019-11-05.
  4. 1 2 3 4 Bruce, C. J. (2011-01-15). "Cardiac tumours: diagnosis and management". Heart. 97 (2): 151–160. doi:10.1136/hrt.2009.186320. ISSN   1355-6037. PMID   21163893. S2CID   43398607.
  5. 1 2 Cho, John M; Danielson, Gordon K; Puga, Francisco J; Dearani, Joseph A; McGregor, Christopher GA; Tazelaar, Henry D; Hagler, Donald J (December 2003). "Surgical resection of ventricular cardiac fibromas: early and late results". The Annals of Thoracic Surgery. 76 (6): 1929–1934. doi:10.1016/s0003-4975(03)01196-2. ISSN   0003-4975. PMID   14667615.
  6. 1 2 3 4 5 Torimitsu, Suguru; Nemoto, Tetsuo; Wakayama, Megumi; Okubo, Yoichiro; Yokose, Tomoyuki; Kitahara, Kanako; Ozawa, Tsukasa; Nakayama, Haruo; Shinozaki, Minoru; Sasai, Daisuke; Ishiwatari, Takao (2012). "Literature survey on epidemiology and pathology of cardiac fibroma". European Journal of Medical Research. 17 (1): 5. doi: 10.1186/2047-783x-17-5 . ISSN   2047-783X. PMC   3351722 . PMID   22472419.
  7. 1 2 Nwachukwu, Harriet; Li, Alice; Nair, Vidhya; Nguyen, Elsie; David, Tirone E.; Butany, Jagdish (July 2011). "Cardiac fibroma in adults". Cardiovascular Pathology. 20 (4): e146–e152. doi:10.1016/j.carpath.2010.08.006. ISSN   1054-8807. PMID   20934889.
  8. 1 2 Parmley, Loren F.; Salley, Robert K.; Williams, J.Powell; Head, G.Bruce (April 1988). "The clinical spectrum of cardiac fibroma with diagnostic and surgical considerations: Noninvasive imaging enhances management". The Annals of Thoracic Surgery. 45 (4): 455–465. doi: 10.1016/s0003-4975(98)90028-5 . ISSN   0003-4975. PMID   3281617.
  9. ↑ "Cardiac Fibroma images, diagnosis, treatment options, answer review - Thoracic Imaging". www.vcuthoracicimaging.com. Retrieved 2019-11-05.
  10. 1 2 Basso, Cristina; Valente, Marialuisa; Thiene, Gaetano (2012-11-28). Cardiac Tumor Pathology. Springer Science & Business Media. ISBN   9781627031431.
  11. ↑ Heath, D. (1969-09-01). "Cardiac fibroma". Heart. 31 (5): 656–658. doi:10.1136/hrt.31.5.656. ISSN   1355-6037. PMC   487558 . PMID   5351306.
  12. ↑ "Cardiac Fibroma". DoveMed. Retrieved 2017-11-06.
  13. 1 2 "Cardiac Tumors | Cleveland Clinic". Cleveland Clinic. Retrieved 2017-12-13.
  14. 1 2 Borodinova O, Ostras O, Raad T, Yemets I (March 2017). "Successful Surgical Excision of a Large Cardiac Fibroma in an Asymptomatic Child". World J Pediatr Congenit Heart Surg. 8 (2): 235–238. doi:10.1177/2150135116634287. PMID   27143716. S2CID   37344382.
  15. 1 2 3 Ying L, Lin R, Gao Z, Qi J, Zhang Z, Gu W (April 2016). "Primary cardiac tumors in children: a center's experience". J Cardiothorac Surg. 11 (1): 52. doi: 10.1186/s13019-016-0448-5 . PMC   4827228 . PMID   27067427.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.